Clinical Trial Update: Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848) [NA]

View source ↗

Summary

A study evaluating controlled inhaled exposure to Resiquimod (R848) to provoke lung innate and mucosal immune responses is currently recruiting. The trial targe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Viral Infection

Drugs mentioned

• Resiquimod (R848) (Resiquimod)

Snippet

Sponsor: Akhilesh Jha | Conditions: Innate Immunity, Mucosal Immunity | NA | Status: RECRUITING